Product Reports Resources Pricing Login Book a demo

OrbusNeich

Health Tech & Medtech · Sha Tin District, Hong Kong · Founded 2005

OrbusNeich is a global leader in the design, development, manufacturing, and marketing of innovative medical devices aimed at treating vascular diseases. The company primarily serves healthcare providers, including hospitals and specialized medical centers, that focus on cardiovascular treatments. Operating in the medical device industry, OrbusNeich's core products include advanced stents and balloon catheters, which are essential for procedures like angioplasty and percutaneous coronary intervention (PCI). The business model revolves around the continuous innovation and improvement of its product line to meet the evolving needs of the cardiovascular healthcare sector. Revenue is generated through the direct sale of these medical devices to healthcare institutions worldwide. OrbusNeich has a strong presence in key markets, including Asia, Europe, and the Americas, and has received regulatory approvals in multiple countries, enhancing its market reach and credibility. Key products like the COMBO Dual Therapy Stent and Sapphire II PRO balloons are designed to improve patient outcomes by reducing complications such as stent thrombosis. The company's commitment to research and development ensures that it remains at the forefront of medical technology, offering solutions that address both current and future healthcare challenges. Keywords: medical devices, vascular diseases, stents, balloon catheters, angioplasty, PCI, cardiovascular, innovation, healthcare, global market.

Valuation $1–2.5B
Revenue $100–500M
Headcount 100–500
Total funding $100–500M
Unlock exact values This page shows ranges. Dealroom has the exact numbers for OrbusNeich and the history behind them.

Investors

7 investors on OrbusNeich's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 6 investors entered at this stage
Shenzhen Capital Group
Galaxy Finance Holding Group
CICC
CCB International
China Merchants Securities
Share Capital
Series B+ 1 investor entered at this stage
Hangzhou Fuyang Industrial Fund Investment Management

Global footprint

Where OrbusNeich has talent and traffic

Workforce by country
20 countries with
team presence
🇳🇱 Netherlands17.6%
🇭🇰 Hong Kong16%
🇲🇾 Malaysia13.6%
🇩🇪 Germany12.8%
🇨🇳 China8%
Top 5 of 20 shown
Web traffic by country
10K monthly visits
across markets
🇺🇸 United States31%
🇻🇳 Vietnam17%
🇭🇰 Hong Kong13%
🇨🇭 Switzerland13%
🇮🇩 Indonesia7%
Top 5 markets shown

Talent graph

The shape of OrbusNeich's talent

Dealroom maps OrbusNeich's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

10 team members profilednamed & role-tagged by Dealroom
239 employeestotal headcount
3 executives & foundersidentified by name
DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock OrbusNeich's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$26M patent portfolio · 90 active families

Estimated portfolio value
$26M
2.6% of valuation · 4.5× smaller than top peer HeartWare International ($120M)
90 active patent families
Where OrbusNeich innovates Biomedical engineeringBlood vesselGeneral surgeryStentBalloon catheter

Where OrbusNeich concentrates vs peers

Each axis is a top-10 topic across OrbusNeich and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about OrbusNeich

An AI-synthesized read of the highest-engagement posts about OrbusNeich on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See OrbusNeich on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.